Amalgamated Bank Sells 10,007 Shares of Colgate-Palmolive (NYSE:CL)

Amalgamated Bank cut its holdings in Colgate-Palmolive (NYSE:CL) by 4.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 199,789 shares of the company’s stock after selling 10,007 shares during the period. Amalgamated Bank’s holdings in Colgate-Palmolive were worth $15,925,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CL. OFI Invest Asset Management bought a new stake in shares of Colgate-Palmolive in the third quarter worth about $25,000. Avion Wealth raised its holdings in shares of Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares in the last quarter. McGlone Suttner Wealth Management Inc. bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $34,000. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Colgate-Palmolive by 142.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares in the last quarter. Finally, West Branch Capital LLC increased its position in Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the transaction, the insider now owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Noel R. Wallace sold 69,948 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the transaction, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 159,048 shares of company stock valued at $13,336,846. 0.34% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Royal Bank of Canada increased their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research report on Monday. Barclays lifted their price target on Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Citigroup upped their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, April 16th. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price for the company. Finally, Wells Fargo & Company increased their price target on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Monday. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Colgate-Palmolive Trading Down 0.0 %

CL traded down $0.03 on Friday, reaching $92.88. 5,432,692 shares of the company traded hands, compared to its average volume of 4,690,854. The company has a market cap of $76.20 billion, a P/E ratio of 29.39, a price-to-earnings-growth ratio of 3.39 and a beta of 0.40. The company has a quick ratio of 0.28, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a one year low of $67.62 and a one year high of $93.25. The firm has a fifty day simple moving average of $88.22 and a two-hundred day simple moving average of $82.07.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period last year, the company posted $0.73 earnings per share. As a group, equities research analysts expect that Colgate-Palmolive will post 3.52 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.15%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.